Does probiotic yeast act as antigenotoxin?

Food Technology and Biotechnology

Volumn 43, Issue 3, 2005, Pages 301-305

  Toma, Malda Maija ^a   Raipulis, Jekabs ^a   Kalnina, Inta ^a   Rutkis, Reinis ^a  

^a UNIVERSITY OF LATVIA   (Latvia)

Author keywords

Antigenotoxicity; Genotoxins; Saccharomyces boulardii; SOS chromotest

Indexed keywords

ANTIGENOTOXIC; ANTIGENOTOXICITY; GENOTOXICITIES; GENOTOXINS; NALIDIXIC ACID; SACCHAROMYCES; SOS CHROMOTEST; TEST ORGANISMS;

ESCHERICHIA COLI; SYSTEMS ENGINEERING; YEAST;

ANTIGENS;

ESCHERICHIA COLI; SACCHAROMYCES BOULARDII;

EID: 23744443026     PISSN: 13309862     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. F. Vergin, Anti- and probiotika, Hippokrates, 25 (1954) 16-119.
2. A.L. D'Souza, C. Rajkumar, J. Cooke, C.J. Bulpitt, Probiotics in prevention of antibiotic associated diarrhea: Meta-analysis, Br. Med. J. 324 (2002) 1361-1364.
3. R. Fuller, Probiotics in man and animals, J. Appl. Bacteriol. 66 (1989) 365-368.
4. P. Periti, F. Tonelli, Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii, J. Chemother. 13 (2001) 473-493.
5. I.V. Pinchuk, P. Bressollier, B. Vernuil, In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics, Antimicrob. Agents Chemother. 45 (2001) 3156-3161.
6. T. Midtvedt: Stellung von Escherichia coli in der Darmökologie: Bestandteil der Mukosabarriere, Symposiumsband zum 3. Interdisc. Symposium Darmflora in Symbiose und Pathogenität, Ansbach (1997) pp. 15-20.
7. B. Lund, C. Edlund, Probiotic Enterococcus faecium strain is a possible recipient of the vanA gene cluster, Clin. Infect. Dis. 32 (2001) 1384-1385.
8. E. Isolauri, P.V. Kirjavainen, S.Salminen, Probiotics: A role in the treatment of intestinal infection and inflammation, Gut, 50 (2002) 54-59.
9. S. Salminen, M.A. Deighton, Y. Benno, S.L. Gorbach: Lactic Acid Bacteria in Health and Disease. In: Lactic Acid Bacteria - Microbiology and Functional Aspects, S. Salminen, A. von Wright (Eds.), Marcel Dekker, Inc., New York (1998) pp. 211-255.
10. S.W. Martin, A.C. Heartherington, G.W. Elmer: Pharmacokinetics of Biotherapeutic Agents. In: Biotherapeutic Agents and Infection Diseases, G.W. Elmer, L. McFarland, C. Surawec (Eds.), Humana Press Inc., Totowa, New York (1999) pp. 7-84.
11. Y. Vandenplas, Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea, Clin. Microbiol. Infect. 5 (1999) 389-395.
12. I. Castagliuolo, M.F. Riegler, L. Valenick, J.T. LaMont, C. Pothoulakis, Sacharomyces boulardii protease inhibits the effects of Clostridium difficile toxin A and B effects in human colonic mucosa, Infect. Immun. 67 (1999) 302-307.
13. C. Hennequin, A. Thierry, G.F. Richard, G. Leontrine, H.V. Nguyen, C. Gaillardin, B. Dujon, Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains, J. Clin. Microbiol. 39 (2001) 551-559.
14. E. Bergogne-Bérézin, Impact écologique de l'antibiothérapie. Place des microorganismes de substitution dans le controle des diarrhées et colites associées aux antibiotiques, Presse Méd. 24 (1995) 145-156.
15. K. Orrhage, E. Sillerstrom, J.A. Gustafsson, C.E. Nord, J. Rafter, Binding of mutagenic heterocyclic amines by intestinal and lactic bacteria, Mutat. Res. 311 (1994) 239-248.
16. P.P. Nair, K.E. Davis, S. Sahmi, A. Lagerholm, The induction of SOS function in Escherichia coli K-12/PQ37 by 4-nitroquinoline-oxide (4-NQO) and fecapentaenes-12 and -14 is bile salt sensitive: Implications for colon carcinogenesis, Mutat. Res. 447 (2000) 179-185.
17. P. Quillardet, M. Hofnung, The SOS chromotest, a colorimetric bacterial assay for genotoxins: Procedures, Mutat. Res. 147 (1985) 235-279.
18. V. Mersh-Sundermann, U. Shneider, G. Klopman, H.S. Rosenkranz, SOS induction in Escherichia coli and Salmonella mutagenicity: A comparison using 330 compounds, Mutagenesis, 9 (1994) 205-224.
19. P. Quillardet, C.D. Bellecombe, M. Hofnung, The SOS chromotest, a colorimetric bacterial assay for genotoxins: Validation study with 83 compounds, Mutat. Res. 147 (1985) 79-85.
20. G. Caldini, F. Trotta, G. Cenci, Inhibition of 4-nitroquinoline-1-oxide genotoxicity by Bacillus strains, Res. Microbiol. 153 (2002) 165-171.
21. J. Raipulis, M.M. Toma, P. Semjonova, The effect of probiotics on the genotoxicity of furazolidone, Int. J. Food. Microbiol. (in press).
22. W.V. Lankaputhra, N.P. Shah, Antimutagenic properties of probiotic bacteria and of organic acids, Mutat. Res. 397 (1998) 169-182.
23. G. Cenci, J. Rossi, F. Trotta, G. Caldini, Lactic acid bacteria isolated from dairy products inhibit genotoxic effect of 4-nitroquinoline-1-oxide in SOS chromotest, Syst. Appl. Microbiol. 25 (2002) 483-490.
24. J.L. Fietto, R.S. Araujo, F.N. Valadao, L.G. Fietto, R.L. Brandao, M.J. Neves, F.C. Gomes, J.R. Nicoli, I.M. Kastro, Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardi, Can. J. Microbiol. 50 (2004) 615-621